Randomized Trial of Lung and Diaphragm Protective Ventilation in Children
NEJM Evidence · 27.05.2025 · 4 (6)
DOI: 10.1056/evidoa2400360 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 27.05.2025. Verfasst von Robinder G Khemani und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles. Hauptthemen laut MEDLINE: Ventilator Weaning, Respiration, Artificial, Respiratory Distress Syndrome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Mechanical ventilation strategies that balance lung and diaphragm protection have not been extensively tested in clinical trials. METHODS: We conducted a single-center, phase II randomized controlled trial in children with acute respiratory distress syndrome with two time points of random assignment: the acute and weaning phases of ventilation. Patients in the intervention group were managed with a computerized decision support (CDS) tool, named REDvent, and esophageal manometry to deliver lung and diaphragm protective ventilation. The control group received usual care. A daily standardized spontaneous breathing trial (SBT) was performed in both groups. The primary outcome was the length of weaning. RESULTS: From October 2017 through March 2024, 248 children were randomly assigned to the acute phase. When participants were triggering the ventilator, the adjusted mean difference (REDvent-acute - usual care-acute) for peak inspiratory pressure was -3 cmH2O (95% CI, -5 to -2), positive end-expiratory pressure was -2 cmH2O (95% CI, -2 to -1), and the esophageal pressure swing was -1.8 cmH2O (95% CI, -3.2 to -0.3). For the primary outcome, 55% of REDvent-acute patients passed their SBT or were extubated on the day of the first SBT, compared with 39% in the usual care-acute group. After adjusting for age, immunosuppression, and oxygenation index value, the REDvent-acute intervention resulted in a 1.67 (95% CI, 1.01 to 2.77; P=0.045) odds of a shorter length of weaning than usual care. The median time from intubation to SBT passage was 3.83 days in the intervention group versus 4.75 days in the usual care group. The length of ventilation among survivors was 5.0 days in the intervention group versus 5.6 days in the usual care group. When comparing weaning phase random assignment, clinical outcomes were similar between groups. There were no differences in adverse events between the groups. CONCLUSIONS: A lung and diaphragm protective ventilation strategy using a CDS tool during the acute phase of ventilation resulted in a shorter length of weaning than usual care. Phase III trials in mechanically ventilated patients are warranted. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT03266016.).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care Medicine, Children's Hospital Los Angeles, Los Angeles.
- Keck School of Medicine, Department of Pediatrics, University of Southern California, Los Angeles.
- Department of Pediatrics, Division of Emergency Medicine, Children's Hospital Los Angeles, Los Angeles.
- School of Nursing, Department of Family and Community Health, University of Pennsylvania, Philadelphia.
- Keck School of Medicine, Department of Population and Public Health Sciences, University of Southern California, Los Angeles.
Zitieren
APA
Khemani, R. G., Bhalla, A., Hotz, J. C., Klein, M. J., Kwok, J., Kohler, K., Bornstein, D., Chang, D., Armenta-Quiroz, A., Vu, K., Smith, E., Suresh, A., Baron, D., Bonilla-Cartagena, J., Ross, P. A., Deakers, T., Beltramo, F., Nelson, L., Shah, S., …, & Newth, C. J. L. (2025). Randomized Trial of Lung and Diaphragm Protective Ventilation in Children. NEJM Evidence, 4(6). https://doi.org/10.1056/evidoa2400360
Vancouver
Khemani RG, Bhalla A, Hotz JC, Klein MJ, Kwok J, Kohler K, et al. Randomized Trial of Lung and Diaphragm Protective Ventilation in Children. NEJM Evidence. 2025;4(6). doi:10.1056/evidoa2400360
BibTeX
@article{Khemani2025,
author = {Khemani, Robinder G and Bhalla, Anoopindar and Hotz, Justin C and Klein, Margaret J and Kwok, Jeni and Kohler, Kristen and Bornstein, Dinnel and Chang, Daniel and Armenta-Quiroz, Anabel and Vu, Kennedy and Smith, Erin and Suresh, Anil and Baron, David and Bonilla-Cartagena, Jennifer and Ross, Patrick A and Deakers, Timothy and Beltramo, Fernando and Nelson, Lara and Shah, Shilpa and Elkunovich, Marsha and Curley, Martha A Q and Mack, Wendy and Newth, Christopher J L},
title = {Randomized Trial of Lung and Diaphragm Protective Ventilation in Children},
journal = {NEJM Evidence},
year = {2025},
volume = {4},
number = {6},
doi = {10.1056/evidoa2400360}
}
EUVIMED